Cargando…
Membrane-bound KIT ligand-targeting DNA vaccination inhibits mammary tumor growth
We have recently demonstrated that a DNA vaccine targeting membrane-bound KIT ligand (KITL) inhibits tumor growth by interfering with vessel stabilization/permeability and by disrupting the recruitment of inflammatory cells and regulatory T cells, the latter being an essential mechanism by which tum...
Autores principales: | Dentelli, Patrizia, Cavallo, Federica, Brizzi, Maria Felice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976984/ https://www.ncbi.nlm.nih.gov/pubmed/24711955 http://dx.doi.org/10.4161/onci.27259 |
Ejemplares similares
-
STING-dependent cytosolic DNA sensor pathways regulate NKG2D ligand expression
por: Le Bert, Nina, et al.
Publicado: (2014) -
Co-stimulatory tumor necrosis factor ligands as adjuvants for the development of subunit-based anticancer vaccines
por: Shirwan, Haval, et al.
Publicado: (2013) -
Inflammatory Microenvironment Promotes Hemopoietic-Derived Angiogenic Cell Expansion and Arterial Specification
por: Dentelli, Patrizia, et al.
Publicado: (2008) -
Use of a KIT-specific monoclonal antibody to bypass imatinib resistance in gastrointestinal stromal tumors
por: Edris, Badreddin, et al.
Publicado: (2013) -
Chemokine-enhanced DNA vaccination in cancer immunotherapy
por: Igoucheva, Olga, et al.
Publicado: (2013)